Use of c-peptide and autoantibodies in individuals clinically labelled as Type 1 to identify those likely to have Type 2 diabetesS. J. McGurnaghan, A. Spiliopoulou,M. Colombo,H. M. Colhoun,P. M. McKeigueDIABETIC MEDICINE(2019)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要